Amarin (NASDAQ:AMRN) Posts Quarterly Earnings Results, Misses Estimates By $0.02 EPS
Amarin (NASDAQ:AMRN – Get Free Report) posted its earnings results on Wednesday. The biopharmaceutical company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.02), Zacks reports. Amarin had a negative return on equity of 7.15% and a negative net margin of 16.33%. The business had revenue of $42.30 […]
More Stories
One Hundred Years of Solitude Season 2: Release Date, Cast Members, Trailer, and More
The best-selling novel One Hundred Years of Solitude by Nobel Prize-winning Colombian author García Márquez is coming back as a...
When Your Payment Provider Can No Longer Keep Up
A payment account can work perfectly well until the business starts growing. Sales rise and customers arrive from new countries,...
The Hawk Season 2 Updates: Where Did Season 1 End
Netflix’s 2026 series, The Hawk, has been released. It has received a mixed response from the audience in different parts...
Netflix’s Upcoming Sports Documentary: Mourinho Is Releasing Soon
Football fans, be ready! Netflix is about to drop one of its most-awaited sports documentaries of 2026. Mourinho is a...
Order of the Sinking Star is Ready to Launch on PlayStation 5 and TV
The creator of Braid and The Witness, Jonathan Blow, is returning with an all-new puzzle video game, Order of the...
Netflix’s Upcoming Drama, All the Truth in My Lies: Release Date, Cast, and More
Excited to know about the upcoming Spanish drama on Netflix, All the Truth in My Lies. If you love watching...